Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma

specific

The reemergence of mature T-cell and NK-cell non-Hodgkin lymphoma after a period of remission.

27

Centers

34

Active Trials

Cancer Funding

Top Centers for Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma(27)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Clinical
High-Volume Research Center
73.5
2
NCI Comprehensive
Active Research Program
68.5
3
NCI Comprehensive
Active Research Program
68.5
4
NCI Comprehensive
Active Research Program
68.5
5
Active Research Program
68.5
6
Active Research Program
68.5
7
NCI Comprehensive
Active Research Program
46.9
8
NCI Comprehensive
Active Research Program
46.9
9
NCI Comprehensive
Active Research Program
46.9
10
NCI Comprehensive
Active Research Program
46.9
11
NCI Comprehensive
Active Research Program
46.9
12
NCI Comprehensive
Active Research Program
46.9
13
NCI Comprehensive
Active Research Program
46.9
14
NCI Comprehensive
Active Research Program
46.9
1546.9
16
NCI Comprehensive
Active Research Program
46.9
17
NCI Comprehensive
Active Research Program
46.9
18
NCI Comprehensive
Active Research Program
46.9
19
NCI Comprehensive
Active Research Program
46.9
20
NCI Comprehensive
Active Research Program
46.9
21
NCI Comprehensive
Active Research Program
46.9
22
NCI Clinical
Active Research Program
46.9
23
NCI Comprehensive
Active Research Program
46.9
24
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
46.9
25
Active Research Program
46.9
26
Active Research Program
46.9
27
BC CancerVancouver, BC
Active Research Program
46.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →